Terence Flynn
Stock Analyst at Morgan Stanley
(4.73)
# 668
Out of 4,495 analysts
1033
Total ratings
59.6%
Success rate
12.3%
Average return
Main Sectors:
Stocks Rated by Terence Flynn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Maintained: Hold | $112 → $113 | $125.99 | -10.31% | 53 | Jul 9, 2026 | |
| AMGN Amgen | Maintained: Hold | $340 → $333 | $367.99 | -9.51% | 54 | Jul 8, 2026 | |
| BIIB Biogen | Maintained: Hold | $224 → $222 | $200.36 | +10.80% | 60 | Jul 8, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,344 → $1,347 | $1,215.83 | +10.79% | 79 | Jul 8, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $168 → $166 | $135.82 | +22.22% | 60 | Jul 8, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $283 → $284 | $263.40 | +7.82% | 55 | Jul 8, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $788 → $730 | $662.88 | +10.13% | 59 | Jul 8, 2026 | |
| MRNA Moderna | Maintained: Hold | $33 → $39 | $73.80 | -47.15% | 35 | Jul 8, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $126 → $119 | $93.53 | +27.23% | 85 | Jul 8, 2026 | |
| PRME Prime Medicine | Maintained: Hold | n/a | $4.62 | - | 12 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $24.05 | +16.42% | 58 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $278 | $252.74 | +9.99% | 53 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $24.31 | +48.09% | 17 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $516 | $554.34 | -6.92% | 33 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $16.64 | +8.17% | 18 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $40 | $57.54 | -30.48% | 48 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $39 | $29.74 | +31.14% | 9 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 | $16.84 | -10.93% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 → $48 | $27.87 | +72.23% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $22 | $30.26 | -27.30% | 15 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $64 | $58.37 | +9.65% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $612 → $616 | $498.43 | +23.59% | 52 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $13.47 | -33.18% | 28 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 | $8.56 | +28.50% | 24 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $126 | $54.89 | +129.55% | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $32 → $33 | $59.20 | -44.26% | 13 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.19 | - | 11 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.67 | n/a | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $16 | $54.29 | n/a | 13 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $12 | $3.83 | n/a | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €91.89 | $138.60 | n/a | 1 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $42.49 | $6.96 | n/a | 1 | Dec 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $16 | $98.07 | n/a | 2 | Mar 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $163 → $155 | $323.50 | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $64.76 | n/a | 1 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $31 | $7.49 | n/a | 4 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $42.76 | n/a | 4 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $38 | $9.65 | n/a | 1 | Nov 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $36 | $7.14 | n/a | 1 | Jul 21, 2015 |
Merck & Co.
Jul 9, 2026
Maintained: Hold
Price Target: $112 → $113
Current: $125.99
Upside: -10.31%
Amgen
Jul 8, 2026
Maintained: Hold
Price Target: $340 → $333
Current: $367.99
Upside: -9.51%
Biogen
Jul 8, 2026
Maintained: Hold
Price Target: $224 → $222
Current: $200.36
Upside: +10.80%
Eli Lilly and Company
Jul 8, 2026
Maintained: Buy
Price Target: $1,344 → $1,347
Current: $1,215.83
Upside: +10.79%
Gilead Sciences
Jul 8, 2026
Maintained: Buy
Price Target: $168 → $166
Current: $135.82
Upside: +22.22%
Johnson & Johnson
Jul 8, 2026
Maintained: Buy
Price Target: $283 → $284
Current: $263.40
Upside: +7.82%
Regeneron Pharmaceuticals
Jul 8, 2026
Maintained: Hold
Price Target: $788 → $730
Current: $662.88
Upside: +10.13%
Moderna
Jul 8, 2026
Maintained: Hold
Price Target: $33 → $39
Current: $73.80
Upside: -47.15%
BioNTech SE
Jul 8, 2026
Maintained: Buy
Price Target: $126 → $119
Current: $93.53
Upside: +27.23%
Prime Medicine
Jul 8, 2026
Maintained: Hold
Price Target: n/a
Current: $4.62
Upside: -
Jun 22, 2026
Maintained: Hold
Price Target: $28
Current: $24.05
Upside: +16.42%
Jun 22, 2026
Maintained: Buy
Price Target: $278
Current: $252.74
Upside: +9.99%
Jun 8, 2026
Maintained: Buy
Price Target: $36
Current: $24.31
Upside: +48.09%
Jun 4, 2026
Maintained: Hold
Price Target: $516
Current: $554.34
Upside: -6.92%
May 28, 2026
Maintained: Buy
Price Target: $18
Current: $16.64
Upside: +8.17%
May 26, 2026
Maintained: Sell
Price Target: $40
Current: $57.54
Upside: -30.48%
May 15, 2026
Maintained: Buy
Price Target: $38 → $39
Current: $29.74
Upside: +31.14%
May 13, 2026
Maintained: Hold
Price Target: $15
Current: $16.84
Upside: -10.93%
May 13, 2026
Maintained: Buy
Price Target: $49 → $48
Current: $27.87
Upside: +72.23%
May 11, 2026
Maintained: Hold
Price Target: $20 → $22
Current: $30.26
Upside: -27.30%
May 7, 2026
Maintained: Buy
Price Target: $63 → $64
Current: $58.37
Upside: +9.65%
May 5, 2026
Rated: Buy
Price Target: $612 → $616
Current: $498.43
Upside: +23.59%
Apr 10, 2026
Maintained: Hold
Price Target: $9
Current: $13.47
Upside: -33.18%
Mar 18, 2026
Maintained: Hold
Price Target: $11
Current: $8.56
Upside: +28.50%
Feb 27, 2026
Maintained: Buy
Price Target: $125 → $126
Current: $54.89
Upside: +129.55%
Feb 17, 2026
Maintained: Sell
Price Target: $32 → $33
Current: $59.20
Upside: -44.26%
Sep 21, 2025
Maintained: Hold
Price Target: n/a
Current: $4.19
Upside: -
Dec 13, 2024
Maintained: Hold
Price Target: n/a
Current: $3.67
Upside: n/a
Jun 1, 2021
Maintained: Sell
Price Target: $16
Current: $54.29
Upside: n/a
Aug 10, 2020
Maintained: Hold
Price Target: $21 → $12
Current: $3.83
Upside: n/a
Aug 3, 2020
Upgraded: Buy
Price Target: €91.89
Current: $138.60
Upside: n/a
Dec 2, 2019
Initiated Coverage: Hold
Price Target: $42.49
Current: $6.96
Upside: n/a
Mar 25, 2019
Downgraded: Hold
Price Target: $18 → $16
Current: $98.07
Upside: n/a
Aug 13, 2018
Maintained: Buy
Price Target: $163 → $155
Current: $323.50
Upside: n/a
Jun 18, 2018
Initiated Coverage: Hold
Price Target: $22
Current: $64.76
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $32 → $31
Current: $7.49
Upside: n/a
Jun 13, 2016
Maintained: Hold
Price Target: $46
Current: $42.76
Upside: n/a
Nov 18, 2015
Rated: Hold
Price Target: $38
Current: $9.65
Upside: n/a
Jul 21, 2015
Initiated Coverage: Hold
Price Target: $36
Current: $7.14
Upside: n/a